Clinical Trials in Maryland

Showing 8301-8320 of 23,284 trials

A Study Evaluating JUVÉDERM® VOLUMA® XC Injectable Gel for Correction of Temple Hollowing in Adult Participants ≥ 22 Years Old

NCT04414397

The objectives of this study are to evaluate the safety and effectiveness of Juvederm® Voluma® XC injectable gel in adult participants seeking correction of temple hollowing

Temple Hollowing

Allergan205 participantsStarted May 2020

Los Angeles, California, United States • Newport Beach, California, United States • Boca Raton, Florida, United States +12 more locations

TERMINATEDPhase 1/217 miles

A Study of Intraperitoneally Administered AVB-001 in Patients With Serous Adenocarcinoma of the Ovary

NCT05538624

This is an open-label, First-in-Human, Phase 1/2, multicenter study to evaluate the safety and efficacy of a single dose of AVB-001. AVB-001 is an encapsulated cell product engineered to produce native human interleukin-2 (hIL-2). It is delivered intraperitoneally (IP) to patients with high grade serous adenocarcinoma of the ovary, primary peritoneum, or fallopian tube.

Neoplasm, OvarianFallopian Tube CancerPrimary Peritoneal Cavity Cancer+5 more

Avenge Bio, Inc14 participantsStarted Dec 2022

Bethesda, Maryland, United States • Boston, Massachusetts, United States • Pittsburgh, Pennsylvania, United States +2 more locations

A Study Evaluating JUVÉDERM® VOLUMA® XC Injectable Gel for Correction of Temple Hollowing in Adult Participants ≥ 22 Years Old

A Study of Intraperitoneally Administered AVB-001 in Patients With Serous Adenocarcinoma of the Ovary

Find Trials by Condition in Maryland

Treatment of Impulsive Aggression (IA) in Adolescent With ADHD in Conjunction With Standard ADHD Treatment

AMP Step Wedge Trial

Management of Chronic Low Back Pain in Older Adults Using Auricular Point Acupressure

Efficacy and Safety of Circadin® in the Treatment of Sleep Disturbances in Children With Neurodevelopment Disabilities

Recent-Onset Type 1 Diabetes Trial Evaluating Efficacy and Safety of Teplizumab

PH 1 Biomarker Study of Nivolumab and Ipilimumab and Nivolumab in Combination With Ipilimumab in Advanced Melanoma

Craniofacial Microsomia: Accelerating Understanding of the Significance and Etiology

The TESLA Trial: Thrombectomy for Emergent Salvage of Large Anterior Circulation Ischemic Stroke

Efficacy and Safety of S95011 in Primary Sjögren's Syndrome Patients

Post Market Study of Parietene™ DS Composite Mesh in Ventral Hernia Repair

Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease

Mogamulizumab Q4week Dosing in Participants With R/R CTCL

Study of Mogamulizumab + MEDI4736 (Durvalumab) and Mogamulizumab + Tremelimumab in Subjects w/ Advanced Solid Tumors

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of Risdiplam (RO7034067) in Type 2 and 3 Spinal Muscular Atrophy (SMA) Participants

Safety Study to Evaluate Monoclonal Antibody KW-0761 in Subjects With Peripheral T-cell Lymphoma

Expanded Access Protocol: Repeated Administration of Nurown® (Autologous MSC-NTF Cells) for the Treatment of ALS

The Effect of Intrawound Vancomycin Powder in Spine Surgery

KHK2455 Alone and in Combination With Mogamulizumab in Subjects With Locally Advanced or Metastatic Solid Tumors